Display options
Share it on

Diabetes Metab Syndr Obes. 2010 Sep 09;3:311-7. doi: 10.2147/DMSOTT.S10744.

Anorexia nervosa depends on adrenal sympathetic hyperactivity: opposite neuroautonomic profile of hyperinsulinism syndrome.

Diabetes, metabolic syndrome and obesity : targets and therapy

Fuad Lechin, Bertha van der Dijs, Betty Pardey-Maldonado, Jairo E Rivera, Scarlet Baez, Marcel E Lechin

Affiliations

  1. Department of Pathophysiology, Sections of Neuroendocrinology, Neuropharmacology, and Neurochemistry, Instituto de Medicina Experimental, Faculty of Medicine, Universidad Central de Venezuela, Caracas.

PMID: 21437100 PMCID: PMC3047992 DOI: 10.2147/DMSOTT.S10744

Abstract

OBJECTIVE: The aim of our study was to determine the central and peripheral autonomic nervous system profiles underlying anorexia nervosa (AN) syndrome, given that affected patients present with the opposite clinical profile to that seen in the hyperinsulinism syndrome.

DESIGN: We measured blood pressure and heart rate, as well as circulating neurotransmitters (noradrenaline, adrenaline, dopamine, plasma serotonin, and platelet serotonin), using high-performance liquid chromatography with electrochemical detection, during supine resting, one minute of orthostasis, and after five minutes of exercise. In total, 22 AN patients (12 binge-eating/purging type and 10 restricting type) and age-, gender-, and race-matched controls (70 ± 10.1% versus 98 ± 3.0% of ideal body weight) were recruited.

RESULTS: We found that patients with AN had adrenal sympathetic overactivity and neural sympathetic underactivity, demonstrated by a predominance of circulating adrenaline over noradrenaline levels, not only during the supine resting state (52 ± 2 versus 29 ± 1 pg/mL) but also during orthostasis (67 ± 3 versus 32 ± 2 pg/mL, P < 0.05) and after exercise challenge (84 ± 4 versus 30 ± 3 pg/mL, P < 0.01).

CONCLUSION: Considering that this peripheral autonomic nervous system disorder depends on the absolute predominance of adrenomedullary C1 adrenergic nuclei over A5 noradrenergic pontine nucleus, let us ratify the abovementioned findings. The AN syndrome depends on the predominance of overwhelming adrenal sympathetic activity over neural sympathetic activity. This combined central and autonomic nervous system profile contrasts with that registered in patients affected by hyperinsulinism, hypoglycemia, and bulimia syndrome which depends on the absolute predominance of neural sympathetic activity.

Keywords: adrenal sympathetic activity; adrenaline; anorexia nervosa; eating disorders; noradrenaline

References

  1. Psychoneuroendocrinology. 1987;12(2):117-29 - PubMed
  2. J Comp Neurol. 1987 Jul 22;261(4):529-42 - PubMed
  3. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jun;30(4):565-85 - PubMed
  4. Eur J Pharmacol. 1989 Dec 12;174(1):127-30 - PubMed
  5. Trends Pharmacol Sci. 2000 Nov;21(11):425 - PubMed
  6. J Neural Transm (Vienna). 1998;105(6-7):561-73 - PubMed
  7. Can J Physiol Pharmacol. 1982 Dec;60(12):1464-74 - PubMed
  8. Neurosci Lett. 2002 Oct 31;332(2):107-10 - PubMed
  9. Diabetes Metab Syndr Obes. 2009 Dec 02;2:203-13 - PubMed
  10. J Hypertens. 2007 Jan;25(1):147-55 - PubMed
  11. Biol Psychiatry. 1989 Mar 15;25(6):799-802 - PubMed
  12. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):214-22 - PubMed
  13. Clin Sci (Lond). 1991 Apr;80(4):373-84 - PubMed
  14. Expert Opin Investig Drugs. 1998 Nov;7(11):1781-93 - PubMed
  15. Am J Hypertens. 1989 Dec;2(12 Pt 2):363S-374S - PubMed
  16. Neuropsychobiology. 1992;26(1-2):4-11 - PubMed
  17. J Pharmacol Sci. 2005 Sep;99(1):52-60 - PubMed
  18. Exp Clin Endocrinol Diabetes. 2000;108(6):389-95 - PubMed
  19. Expert Opin Investig Drugs. 1999 May;8(5):575-84 - PubMed
  20. J Neural Transm (Vienna). 2001;108(7):793-801 - PubMed
  21. Psychosom Med. 1979 Dec;41(8):661-72 - PubMed
  22. J Comp Neurol. 1996 Jan 15;364(3):402-413 - PubMed
  23. Diabetologia. 1983 Nov;25(5):377-81 - PubMed
  24. Biol Psychiatry. 1981 Oct;16(10):969-86 - PubMed
  25. Clin Exp Hypertens. 1993 Jan;15(1):209-40 - PubMed
  26. J Comp Neurol. 1992 Mar 22;317(4):379-95 - PubMed
  27. J Clin Endocrinol Metab. 1985 Dec;61(6):1053-60 - PubMed
  28. J Clin Endocrinol Metab. 1983 Nov;57(5):911-4 - PubMed
  29. Pharmacol Rev. 2000 Dec;52(4):595-638 - PubMed
  30. J Neural Transm (Vienna). 2010 Mar;117(3):293-9 - PubMed
  31. Brain Res. 1989 Jul 3;491(1):156-62 - PubMed
  32. Neuroscience. 2005;132(4):991-1007 - PubMed
  33. Diabetes. 2005 May;54(5):1447-51 - PubMed
  34. J Auton Nerv Syst. 1988 Aug;23(2):161-74 - PubMed
  35. Clin Sci (Lond). 2008 May;114(9):589-90 - PubMed
  36. Biol Psychiatry. 1995 Aug 1;38(3):166-73 - PubMed
  37. Am J Physiol. 1994 Mar;266(3 Pt 2):H1075-86 - PubMed
  38. Br J Pharmacol. 1989 Aug;97(4):1067-74 - PubMed
  39. Neuroendocrinology. 1985 Aug;41(2):156-62 - PubMed
  40. Gut. 1993 Feb;34(2):166-72 - PubMed
  41. Acta Physiol Lat Am. 1975;25(4):339-46 - PubMed
  42. J Neurosci. 1990 Jul;10(7):2139-47 - PubMed
  43. Dig Dis Sci. 2009 Mar;54(3):458-70 - PubMed
  44. Neuroendocrinology. 2006;84(4):222-34 - PubMed
  45. Dig Dis Sci. 1990 Nov;35(11):1313-9 - PubMed
  46. Brain Res. 1999 Jan 9;815(2):227-36 - PubMed
  47. Physiol Rev. 1994 Apr;74(2):323-64 - PubMed
  48. Brain Res. 1989 Jul 10;491(2):274-96 - PubMed
  49. Brain Res. 1994 Feb 28;638(1-2):248-60 - PubMed
  50. Eksp Klin Farmakol. 2005 Jan-Feb;68(1):36-8 - PubMed
  51. J Comp Neurol. 1989 Dec 22;290(4):561-84 - PubMed

Publication Types